Table 3 Summary of top five in –frame and out -of frame problems
Top 5 mentioned problems (in-frame issues) | Bottom 5 mentioned problems (Out -of -frame issues) |
|---|---|
Availability of medicines | Corruption |
Procurement and supply chain management | Pricing/High Out of Pocket expenditure |
Regulatory weakness | Missing medicnes |
Product quality | Weak accountability |
Fasified and substandard medicines | Low R & D |